The forecast for sold production of chemical contraceptive preparations based on hormones or spermicides in France indicates a declining trend from 2024 onwards. Starting at €4.5216 million in 2024, the value progressively decreases to €0.91941 million by 2028. Compared to 2023, the market is experiencing a significant downtrend with a compounded annual growth rate (CAGR) showing an average negative variation over these forecasted years.
Future trends to monitor include:
- Potential shifts in consumer preferences towards non-hormonal or natural contraceptives.
- Impact of regulatory changes or health initiatives promoting alternative contraceptive methods.
- Innovations in the contraceptive market that may alter current trends.
- Societal shifts such as declining birth rates impacting the demand for contraceptives.
